We performed a bioinformatic analysis of publicly available transcriptome data and found that patients with T-ALL exhibited higher expression of Skp2 in comparison with B-ALL patients (Fig. 5a, far left panel). This evidence concerns the gene SKP2 and acute lymphoblastic leukemia.